Is it time to revisit residual renal function in haemodialysis?
- PMID: 17498114
- DOI: 10.1111/j.1440-1797.2007.00795.x
Is it time to revisit residual renal function in haemodialysis?
Abstract
Residual renal function (RRF) is not currently emphasized for patients undergoing haemodialysis (HD). The role of RRF is well recognized in the peritoneal dialysis population as studies have clearly demonstrated a survival benefit with preservation of RRF. There is however, data to suggest that RRF is important in HD patients as well. Contemporary HD therapies using high flux biocompatible synthetic dialysers, bicarbonate buffered ultrapure dialysis fluids with ultrafiltration control appear to allow better preservation of RRF. The long held belief that peritoneal dialysis is better at preserving RRF than HD may no longer be true. More robust studies are required to determine the relative importance of RRF in HD and strategies to best preserve this vital asset.
Similar articles
-
Residual renal function: considerations on its importance and preservation in dialysis patients.Semin Dial. 2004 May-Jun;17(3):196-201. doi: 10.1111/j.0894-0959.2004.17306.x. Semin Dial. 2004. PMID: 15144545 Review.
-
Clinical benefit of preserving residual renal function in patients after initiation of dialysis.Blood Purif. 2004;22 Suppl 2:67-71. doi: 10.1159/000081878. Blood Purif. 2004. PMID: 15655327 Review.
-
Peritoneal dialysis compared with hemodialysis in the treatment of end-stage renal disease.J Nephrol. 2000 Sep-Oct;13(5):331-42. J Nephrol. 2000. PMID: 11063136 Review.
-
Emerging importance of residual renal function in end-stage renal failure.Semin Dial. 2011 Sep-Oct;24(5):487-94. doi: 10.1111/j.1525-139X.2011.00968.x. Semin Dial. 2011. PMID: 21999737 Review.
-
Disordered mineral metabolism is not a risk factor for loss of residual renal function in dialysis patients.Nephrol Dial Transplant. 2009 May;24(5):1580-7. doi: 10.1093/ndt/gfn768. Epub 2009 Jan 20. Nephrol Dial Transplant. 2009. PMID: 19155531
Cited by
-
Anti-inflammatory and renoprotective effects of difelikefalin, a kappa opioid receptor agonist, in a rat model of renal ischemia-reperfusion-induced acute kidney injury.BMC Nephrol. 2025 Jul 1;26(1):307. doi: 10.1186/s12882-025-04199-9. BMC Nephrol. 2025. PMID: 40596915 Free PMC article.
-
Contribution of residual function to removal of protein-bound solutes in hemodialysis.Clin J Am Soc Nephrol. 2011 Feb;6(2):290-6. doi: 10.2215/CJN.06100710. Epub 2010 Oct 28. Clin J Am Soc Nephrol. 2011. PMID: 21030575 Free PMC article.
-
High-sensitivity C-reactive protein, apolipoproteins, and residual diuresis in chronic kidney disease patients undergoing hemodialysis.Clin Exp Nephrol. 2016 Dec;20(6):943-950. doi: 10.1007/s10157-016-1230-7. Epub 2016 Jan 14. Clin Exp Nephrol. 2016. PMID: 26768861
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical